Skip to content
Back to News
ArticleBy Record desk

How a 2016 Trump Tower meeting planted the seed of federal vaccine review

Why it matters

The 2025 federal autism actions did not appear from nowhere. Their political origin traces directly to a January 2017 meeting and the network of advocates, Kennedy, Wakefield, and Florida donor Gary Kompothecras, who pressed the case a decade ago.

Robert F. Kennedy Jr. and President Trump

In January 2017, Robert F. Kennedy Jr. said that President-elect Donald Trump had asked him to chair a commission on vaccine safety and scientific integrity, following a meeting at Trump Tower. Trump’s transition team then said it was exploring a commission on autism but had made no final decision.

During the 2016 campaign and transition, Trump had met with prominent vaccine-safety advocates, including Andrew Wakefield and Florida donor Gary Kompothecras, to discuss vaccine policy and the contested vaccine–autism question.

The commission never formally launched at the time. But the relationships and arguments established in that period are the direct antecedents of the 2025 HHS actions under Secretary Kennedy, a nearly decade-long arc from private advocacy to federal policy.

Source

Reuters

Related coverage

A presidential desk with a signed document, a fountain pen, and an American flag out of focusPost
AJF Original

“Kennedy is the saving grace”: Trump moves to remake the childhood schedule, and what is actually in force

In the span of six weeks the President signed an order cutting routine childhood vaccines from 18 diseases to 11, then stood beside Robert F. Kennedy Jr. and proposed splitting shots into five smaller doses. A viral clip called it a schedule of 72 shots reduced to 11 “by the stroke of a pen.” That is the biggest shift in federal vaccine posture in a generation, and it is also not yet law. Here is the record, and the reaction, side by side.